InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
87.18
(
0.30%
)
Bitcoin
58,025.66
(
-3.55%
)
Post# of 4973675
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Deewar25

Send PM Follow Ignore
Followers 66
Posts 1920
Boards Moderated 1
Alias Born 06/14/2001

Deewar25

Member Level

Re: None

Wednesday, 01/07/2009 12:30:25 PM

Wednesday, January 07, 2009 12:30:25 PM

Post# of 4973675
ANX bio at 0.12, company already said in negotiations with partner for marketing their drugs - a safer profile of ones currently on the market with a $3.2 billion market share! They anticipate they could be to market next year with these.

Slowing things down to conserve cash while negotiations are ongoing, and they have no debt...pretty damn fine risk/reward at 0.12 considering all the other speculative runners with less prospect.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up